Cancer stem cells (CSCs) refer to the cells obtained from tumor that posses potential to reproduce all types of cancer cells found in a cancer sample. Cancer stem cells are planned to grow in tumors as a separate population and thereby cause deterioration and metastasis of existing tumor through generation of new tumor. Thus, with advancement in technology especially in cancer stem cells research area, therapies specific to targeting cancer stem cells are expected to improve quality of life and survival cases of cancer patients with metastatic diseases.
This report aims to provide a comprehensive presentation of the global market for Cancer Stem Cell, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Stem Cell. This report contains market size and forecasts of Cancer Stem Cell in global, including the following market information:
Global Cancer Stem Cell Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Cancer Stem Cell market was valued at US$ 1086.9 million in 2022 and is projected to reach US$ 1777.9 million by 2029, at a CAGR of 7.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America was the leading revenue contributor of the cancer stem cells market in 2016 due to presence of a substantial number of organizations engaged in conducting R&D activities related to stem cell therapy. There are several internationally recognized hospitals and medical institutes, such as Cancer Treatment Centers of America at Midwestern Regional Medical Center, which offer stem cell transplant therapies.
Asia Pacific is expected to be a promising region in the arena owing to presence of several organizations in the region that focus on R&D of stem cells. Moreover, funding agencies are providing grants to research communities to accelerate their scientific research on cancer stem cells in Asian countries.
We surveyed the Cancer Stem Cell companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Stem Cell Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Cancer Stem Cell Market Segment Percentages, by Type, 2022 (%)
Cell Culturing
Cell Separation
Cell Analysis
Molecular Analysis
Others
Global Cancer Stem Cell Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Cancer Stem Cell Market Segment Percentages, by Application, 2022 (%)
Stem Cell Based Cancer Therapy
Targeted CSCs
Global Cancer Stem Cell Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Cancer Stem Cell Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Stem Cell revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cancer Stem Cell revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific, Inc.
AbbVie, Inc.
Merck KGaA
Bionomics
Lonza
Stemline Therapeutics, Inc.
Miltenyi Biotec
PromoCell GmbH
MacroGenics, Inc.
OncoMed Pharmaceuticals, Inc.
Irvine Scientific
STEMCELL Technologies Inc.
Sino Biological Inc.
BIOTIME, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Stem Cell, market overview.
Chapter 2: Global Cancer Stem Cell market size in revenue.
Chapter 3: Detailed analysis of Cancer Stem Cell company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Stem Cell in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Stem Cell Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Stem Cell Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Stem Cell Overall Market Size
2.1 Global Cancer Stem Cell Market Size: 2022 VS 2029
2.2 Global Cancer Stem Cell Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Stem Cell Players in Global Market
3.2 Top Global Cancer Stem Cell Companies Ranked by Revenue
3.3 Global Cancer Stem Cell Revenue by Companies
3.4 Top 3 and Top 5 Cancer Stem Cell Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancer Stem Cell Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Stem Cell Players in Global Market
3.6.1 List of Global Tier 1 Cancer Stem Cell Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Stem Cell Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Stem Cell Market Size Markets, 2022 & 2029
4.1.2 Cell Culturing
4.1.3 Cell Separation
4.1.4 Cell Analysis
4.1.5 Molecular Analysis
4.1.6 Others
4.2 By Type - Global Cancer Stem Cell Revenue & Forecasts
4.2.1 By Type - Global Cancer Stem Cell Revenue, 2018-2023
4.2.2 By Type - Global Cancer Stem Cell Revenue, 2024-2029
4.2.3 By Type - Global Cancer Stem Cell Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Stem Cell Market Size, 2022 & 2029
5.1.2 Stem Cell Based Cancer Therapy
5.1.3 Targeted CSCs
5.2 By Application - Global Cancer Stem Cell Revenue & Forecasts
5.2.1 By Application - Global Cancer Stem Cell Revenue, 2018-2023
5.2.2 By Application - Global Cancer Stem Cell Revenue, 2024-2029
5.2.3 By Application - Global Cancer Stem Cell Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Cancer Stem Cell Market Size, 2022 & 2029
6.2 By Region - Global Cancer Stem Cell Revenue & Forecasts
6.2.1 By Region - Global Cancer Stem Cell Revenue, 2018-2023
6.2.2 By Region - Global Cancer Stem Cell Revenue, 2024-2029
6.2.3 By Region - Global Cancer Stem Cell Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Cancer Stem Cell Revenue, 2018-2029
6.3.2 US Cancer Stem Cell Market Size, 2018-2029
6.3.3 Canada Cancer Stem Cell Market Size, 2018-2029
6.3.4 Mexico Cancer Stem Cell Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Cancer Stem Cell Revenue, 2018-2029
6.4.2 Germany Cancer Stem Cell Market Size, 2018-2029
6.4.3 France Cancer Stem Cell Market Size, 2018-2029
6.4.4 U.K. Cancer Stem Cell Market Size, 2018-2029
6.4.5 Italy Cancer Stem Cell Market Size, 2018-2029
6.4.6 Russia Cancer Stem Cell Market Size, 2018-2029
6.4.7 Nordic Countries Cancer Stem Cell Market Size, 2018-2029
6.4.8 Benelux Cancer Stem Cell Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Cancer Stem Cell Revenue, 2018-2029
6.5.2 China Cancer Stem Cell Market Size, 2018-2029
6.5.3 Japan Cancer Stem Cell Market Size, 2018-2029
6.5.4 South Korea Cancer Stem Cell Market Size, 2018-2029
6.5.5 Southeast Asia Cancer Stem Cell Market Size, 2018-2029
6.5.6 India Cancer Stem Cell Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Cancer Stem Cell Revenue, 2018-2029
6.6.2 Brazil Cancer Stem Cell Market Size, 2018-2029
6.6.3 Argentina Cancer Stem Cell Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Stem Cell Revenue, 2018-2029
6.7.2 Turkey Cancer Stem Cell Market Size, 2018-2029
6.7.3 Israel Cancer Stem Cell Market Size, 2018-2029
6.7.4 Saudi Arabia Cancer Stem Cell Market Size, 2018-2029
6.7.5 UAE Cancer Stem Cell Market Size, 2018-2029
7 Cancer Stem Cell Companies Profiles
7.1 Thermo Fisher Scientific, Inc.
7.1.1 Thermo Fisher Scientific, Inc. Company Summary
7.1.2 Thermo Fisher Scientific, Inc. Business Overview
7.1.3 Thermo Fisher Scientific, Inc. Cancer Stem Cell Major Product Offerings
7.1.4 Thermo Fisher Scientific, Inc. Cancer Stem Cell Revenue in Global Market (2018-2023)
7.1.5 Thermo Fisher Scientific, Inc. Key News & Latest Developments
7.2 AbbVie, Inc.
7.2.1 AbbVie, Inc. Company Summary
7.2.2 AbbVie, Inc. Business Overview
7.2.3 AbbVie, Inc. Cancer Stem Cell Major Product Offerings
7.2.4 AbbVie, Inc. Cancer Stem Cell Revenue in Global Market (2018-2023)
7.2.5 AbbVie, Inc. Key News & Latest Developments
7.3 Merck KGaA
7.3.1 Merck KGaA Company Summary
7.3.2 Merck KGaA Business Overview
7.3.3 Merck KGaA Cancer Stem Cell Major Product Offerings
7.3.4 Merck KGaA Cancer Stem Cell Revenue in Global Market (2018-2023)
7.3.5 Merck KGaA Key News & Latest Developments
7.4 Bionomics
7.4.1 Bionomics Company Summary
7.4.2 Bionomics Business Overview
7.4.3 Bionomics Cancer Stem Cell Major Product Offerings
7.4.4 Bionomics Cancer Stem Cell Revenue in Global Market (2018-2023)
7.4.5 Bionomics Key News & Latest Developments
7.5 Lonza
7.5.1 Lonza Company Summary
7.5.2 Lonza Business Overview
7.5.3 Lonza Cancer Stem Cell Major Product Offerings
7.5.4 Lonza Cancer Stem Cell Revenue in Global Market (2018-2023)
7.5.5 Lonza Key News & Latest Developments
7.6 Stemline Therapeutics, Inc.
7.6.1 Stemline Therapeutics, Inc. Company Summary
7.6.2 Stemline Therapeutics, Inc. Business Overview
7.6.3 Stemline Therapeutics, Inc. Cancer Stem Cell Major Product Offerings
7.6.4 Stemline Therapeutics, Inc. Cancer Stem Cell Revenue in Global Market (2018-2023)
7.6.5 Stemline Therapeutics, Inc. Key News & Latest Developments
7.7 Miltenyi Biotec
7.7.1 Miltenyi Biotec Company Summary
7.7.2 Miltenyi Biotec Business Overview
7.7.3 Miltenyi Biotec Cancer Stem Cell Major Product Offerings
7.7.4 Miltenyi Biotec Cancer Stem Cell Revenue in Global Market (2018-2023)
7.7.5 Miltenyi Biotec Key News & Latest Developments
7.8 PromoCell GmbH
7.8.1 PromoCell GmbH Company Summary
7.8.2 PromoCell GmbH Business Overview
7.8.3 PromoCell GmbH Cancer Stem Cell Major Product Offerings
7.8.4 PromoCell GmbH Cancer Stem Cell Revenue in Global Market (2018-2023)
7.8.5 PromoCell GmbH Key News & Latest Developments
7.9 MacroGenics, Inc.
7.9.1 MacroGenics, Inc. Company Summary
7.9.2 MacroGenics, Inc. Business Overview
7.9.3 MacroGenics, Inc. Cancer Stem Cell Major Product Offerings
7.9.4 MacroGenics, Inc. Cancer Stem Cell Revenue in Global Market (2018-2023)
7.9.5 MacroGenics, Inc. Key News & Latest Developments
7.10 OncoMed Pharmaceuticals, Inc.
7.10.1 OncoMed Pharmaceuticals, Inc. Company Summary
7.10.2 OncoMed Pharmaceuticals, Inc. Business Overview
7.10.3 OncoMed Pharmaceuticals, Inc. Cancer Stem Cell Major Product Offerings
7.10.4 OncoMed Pharmaceuticals, Inc. Cancer Stem Cell Revenue in Global Market (2018-2023)
7.10.5 OncoMed Pharmaceuticals, Inc. Key News & Latest Developments
7.11 Irvine Scientific
7.11.1 Irvine Scientific Company Summary
7.11.2 Irvine Scientific Business Overview
7.11.3 Irvine Scientific Cancer Stem Cell Major Product Offerings
7.11.4 Irvine Scientific Cancer Stem Cell Revenue in Global Market (2018-2023)
7.11.5 Irvine Scientific Key News & Latest Developments
7.12 STEMCELL Technologies Inc.
7.12.1 STEMCELL Technologies Inc. Company Summary
7.12.2 STEMCELL Technologies Inc. Business Overview
7.12.3 STEMCELL Technologies Inc. Cancer Stem Cell Major Product Offerings
7.12.4 STEMCELL Technologies Inc. Cancer Stem Cell Revenue in Global Market (2018-2023)
7.12.5 STEMCELL Technologies Inc. Key News & Latest Developments
7.13 Sino Biological Inc.
7.13.1 Sino Biological Inc. Company Summary
7.13.2 Sino Biological Inc. Business Overview
7.13.3 Sino Biological Inc. Cancer Stem Cell Major Product Offerings
7.13.4 Sino Biological Inc. Cancer Stem Cell Revenue in Global Market (2018-2023)
7.13.5 Sino Biological Inc. Key News & Latest Developments
7.14 BIOTIME, Inc.
7.14.1 BIOTIME, Inc. Company Summary
7.14.2 BIOTIME, Inc. Business Overview
7.14.3 BIOTIME, Inc. Cancer Stem Cell Major Product Offerings
7.14.4 BIOTIME, Inc. Cancer Stem Cell Revenue in Global Market (2018-2023)
7.14.5 BIOTIME, Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Stem Cell Market Opportunities & Trends in Global Market
Table 2. Cancer Stem Cell Market Drivers in Global Market
Table 3. Cancer Stem Cell Market Restraints in Global Market
Table 4. Key Players of Cancer Stem Cell in Global Market
Table 5. Top Cancer Stem Cell Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cancer Stem Cell Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cancer Stem Cell Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cancer Stem Cell Product Type
Table 9. List of Global Tier 1 Cancer Stem Cell Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Stem Cell Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cancer Stem Cell Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Cancer Stem Cell Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cancer Stem Cell Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Cancer Stem Cell Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Cancer Stem Cell Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cancer Stem Cell Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Cancer Stem Cell Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Cancer Stem Cell Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cancer Stem Cell Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Cancer Stem Cell Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cancer Stem Cell Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Cancer Stem Cell Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cancer Stem Cell Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Cancer Stem Cell Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cancer Stem Cell Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Cancer Stem Cell Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cancer Stem Cell Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Cancer Stem Cell Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cancer Stem Cell Revenue, (US$, Mn), 2024-2029
Table 30. Thermo Fisher Scientific, Inc. Company Summary
Table 31. Thermo Fisher Scientific, Inc. Cancer Stem Cell Product Offerings
Table 32. Thermo Fisher Scientific, Inc. Cancer Stem Cell Revenue (US$, Mn) & (2018-2023)
Table 33. Thermo Fisher Scientific, Inc. Key News & Latest Developments
Table 34. AbbVie, Inc. Company Summary
Table 35. AbbVie, Inc. Cancer Stem Cell Product Offerings
Table 36. AbbVie, Inc. Cancer Stem Cell Revenue (US$, Mn) & (2018-2023)
Table 37. AbbVie, Inc. Key News & Latest Developments
Table 38. Merck KGaA Company Summary
Table 39. Merck KGaA Cancer Stem Cell Product Offerings
Table 40. Merck KGaA Cancer Stem Cell Revenue (US$, Mn) & (2018-2023)
Table 41. Merck KGaA Key News & Latest Developments
Table 42. Bionomics Company Summary
Table 43. Bionomics Cancer Stem Cell Product Offerings
Table 44. Bionomics Cancer Stem Cell Revenue (US$, Mn) & (2018-2023)
Table 45. Bionomics Key News & Latest Developments
Table 46. Lonza Company Summary
Table 47. Lonza Cancer Stem Cell Product Offerings
Table 48. Lonza Cancer Stem Cell Revenue (US$, Mn) & (2018-2023)
Table 49. Lonza Key News & Latest Developments
Table 50. Stemline Therapeutics, Inc. Company Summary
Table 51. Stemline Therapeutics, Inc. Cancer Stem Cell Product Offerings
Table 52. Stemline Therapeutics, Inc. Cancer Stem Cell Revenue (US$, Mn) & (2018-2023)
Table 53. Stemline Therapeutics, Inc. Key News & Latest Developments
Table 54. Miltenyi Biotec Company Summary
Table 55. Miltenyi Biotec Cancer Stem Cell Product Offerings
Table 56. Miltenyi Biotec Cancer Stem Cell Revenue (US$, Mn) & (2018-2023)
Table 57. Miltenyi Biotec Key News & Latest Developments
Table 58. PromoCell GmbH Company Summary
Table 59. PromoCell GmbH Cancer Stem Cell Product Offerings
Table 60. PromoCell GmbH Cancer Stem Cell Revenue (US$, Mn) & (2018-2023)
Table 61. PromoCell GmbH Key News & Latest Developments
Table 62. MacroGenics, Inc. Company Summary
Table 63. MacroGenics, Inc. Cancer Stem Cell Product Offerings
Table 64. MacroGenics, Inc. Cancer Stem Cell Revenue (US$, Mn) & (2018-2023)
Table 65. MacroGenics, Inc. Key News & Latest Developments
Table 66. OncoMed Pharmaceuticals, Inc. Company Summary
Table 67. OncoMed Pharmaceuticals, Inc. Cancer Stem Cell Product Offerings
Table 68. OncoMed Pharmaceuticals, Inc. Cancer Stem Cell Revenue (US$, Mn) & (2018-2023)
Table 69. OncoMed Pharmaceuticals, Inc. Key News & Latest Developments
Table 70. Irvine Scientific Company Summary
Table 71. Irvine Scientific Cancer Stem Cell Product Offerings
Table 72. Irvine Scientific Cancer Stem Cell Revenue (US$, Mn) & (2018-2023)
Table 73. Irvine Scientific Key News & Latest Developments
Table 74. STEMCELL Technologies Inc. Company Summary
Table 75. STEMCELL Technologies Inc. Cancer Stem Cell Product Offerings
Table 76. STEMCELL Technologies Inc. Cancer Stem Cell Revenue (US$, Mn) & (2018-2023)
Table 77. STEMCELL Technologies Inc. Key News & Latest Developments
Table 78. Sino Biological Inc. Company Summary
Table 79. Sino Biological Inc. Cancer Stem Cell Product Offerings
Table 80. Sino Biological Inc. Cancer Stem Cell Revenue (US$, Mn) & (2018-2023)
Table 81. Sino Biological Inc. Key News & Latest Developments
Table 82. BIOTIME, Inc. Company Summary
Table 83. BIOTIME, Inc. Cancer Stem Cell Product Offerings
Table 84. BIOTIME, Inc. Cancer Stem Cell Revenue (US$, Mn) & (2018-2023)
Table 85. BIOTIME, Inc. Key News & Latest Developments
List of Figures
Figure 1. Cancer Stem Cell Segment by Type in 2022
Figure 2. Cancer Stem Cell Segment by Application in 2022
Figure 3. Global Cancer Stem Cell Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cancer Stem Cell Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Cancer Stem Cell Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Stem Cell Revenue in 2022
Figure 8. By Type - Global Cancer Stem Cell Revenue Market Share, 2018-2029
Figure 9. By Application - Global Cancer Stem Cell Revenue Market Share, 2018-2029
Figure 10. By Type - Global Cancer Stem Cell Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Cancer Stem Cell Revenue Market Share, 2018-2029
Figure 12. By Application - Global Cancer Stem Cell Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Cancer Stem Cell Revenue Market Share, 2018-2029
Figure 14. By Region - Global Cancer Stem Cell Revenue Market Share, 2018-2029
Figure 15. By Country - North America Cancer Stem Cell Revenue Market Share, 2018-2029
Figure 16. US Cancer Stem Cell Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Cancer Stem Cell Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Cancer Stem Cell Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Cancer Stem Cell Revenue Market Share, 2018-2029
Figure 20. Germany Cancer Stem Cell Revenue, (US$, Mn), 2018-2029
Figure 21. France Cancer Stem Cell Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Cancer Stem Cell Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Cancer Stem Cell Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Cancer Stem Cell Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Cancer Stem Cell Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Cancer Stem Cell Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Cancer Stem Cell Revenue Market Share, 2018-2029
Figure 28. China Cancer Stem Cell Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Cancer Stem Cell Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Cancer Stem Cell Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Cancer Stem Cell Revenue, (US$, Mn), 2018-2029
Figure 32. India Cancer Stem Cell Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Cancer Stem Cell Revenue Market Share, 2018-2029
Figure 34. Brazil Cancer Stem Cell Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Cancer Stem Cell Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Cancer Stem Cell Revenue Market Share, 2018-2029
Figure 37. Turkey Cancer Stem Cell Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Cancer Stem Cell Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Cancer Stem Cell Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Cancer Stem Cell Revenue, (US$, Mn), 2018-2029
Figure 41. Thermo Fisher Scientific, Inc. Cancer Stem Cell Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. AbbVie, Inc. Cancer Stem Cell Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Merck KGaA Cancer Stem Cell Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bionomics Cancer Stem Cell Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Lonza Cancer Stem Cell Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Stemline Therapeutics, Inc. Cancer Stem Cell Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Miltenyi Biotec Cancer Stem Cell Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. PromoCell GmbH Cancer Stem Cell Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. MacroGenics, Inc. Cancer Stem Cell Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. OncoMed Pharmaceuticals, Inc. Cancer Stem Cell Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Irvine Scientific Cancer Stem Cell Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. STEMCELL Technologies Inc. Cancer Stem Cell Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Sino Biological Inc. Cancer Stem Cell Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. BIOTIME, Inc. Cancer Stem Cell Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
